Molecular Formula | C19H32O7 |
Molar Mass | 372.45 |
Density | 1.097±0.06 g/cm3(Predicted) |
Boling Point | 473.6±40.0 °C(Predicted) |
pKa | 14.36±0.10(Predicted) |
Storage Condition | Room Temprature |
Refractive Index | 1.4920 to 1.4960 |
MDL | MFCD06797107 |
Physical and Chemical Properties | Bioactive BnO-PEG6-OH is a non-cleavable ADC linker containing 6-unit PEG, which can be used to synthesize antibody-coupled drugs (ADC). BnO-PEG6-OH is also a PROTAC linker, which belongs to the PEG class and can be used to synthesize PROTAC molecules. |
In vitro study | ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins. |
Raw Materials | Hexaethylene glycol Tosylate of Triethylene glycol monobenzyl ether Benzyl chloride Benzyl bromide Triethylene glycol |
biological activity | BnO-PEG6-OH is a non-cleavable ADC linker containing 6-unit PEG, which can be used to synthesize antibody-coupled drugs (ADC). BnO-PEG6-OH is also a PROTAC linker, belonging to the PEG class, which can be used to synthesize PROTAC molecules. |
target | Non-cleavable PEGs |
in vitro study | ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker. PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins. |
target
Non-cleavable PEGs
in vitro study
ADCs are comprised of an antibody to which is attached an ADC cytotoxin through an ADC linker.
PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.